Mackay; Charles
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mackay; Charles.The latest application filed is for "antibody with specificity for gm-csf (ii)".
- Mackay; Charles - Vavcluse N/A AU
- MacKay; Charles - Prahran N/A AU
- Mackay; Charles - Vaucluse NSW AU
- Mackay; Charles - Vaucluse AU
- Mackay; Charles - New South Wales AU
- Mackay; Charles - Newton Highlands MA
- Mackay, Charles - Watertown MA
| Patent | Date |
|---|---|
| Antibody with specificity for GM-CSF (I) Grant 9,567,397 - Magnenat , et al. February 14, 2 | 2017-02-14 |
| Antibody with specificity for GM-CSF (II) Grant 9,567,398 - Magnenat , et al. February 14, 2 | 2017-02-14 |
| Antibody With Specificity For Gm-csf (ii) App 20140065163 - Magnenat; Laurent ; et al. | 2014-03-06 |
| Antibody With Specificity For Gm-csf (i) App 20140023641 - Magnenant; Laurent ; et al. | 2014-01-23 |
| Humanized Anti-c5ar Antibodies App 20120315275 - Whitefeld; Peter ; et al. | 2012-12-13 |
| Humanized anti-C5aR antibodies Grant 8,268,972 - Whitfeld , et al. September 18, 2 | 2012-09-18 |
| Modified animal lacking functional PYY gene, monoclonal antibodies that bind PYY isoforms and uses therefor Grant 8,236,933 - Herzog , et al. August 7, 2 | 2012-08-07 |
| Humanized Anti-C5aR Antibodies App 20110190477 - Whitfeld; Peter ; et al. | 2011-08-04 |
| Neutralizing Antibodies App 20110044996 - Mackay; Charles ; et al. | 2011-02-24 |
| Method of diagnosis of inflammatory disease using eotaxin antibodies Grant 7,858,326 - Ponath , et al. December 28, 2 | 2010-12-28 |
| Epitope For Neutralizing Antibodies App 20100297135 - Mackay; Charles ; et al. | 2010-11-25 |
| Modified animal lacking functional PYY gene, monoclonal antibodies that bind PYY isoforms and uses therefor App 20100143934 - Herzog; Herbert ; et al. | 2010-06-10 |
| Human chemotactic cytokine App 20090110659 - Ponath; Paul D. ; et al. | 2009-04-30 |
| Use of Baff to Treat Th2-Mediated Conditions App 20080254030 - Mackay; Charles ; et al. | 2008-10-16 |
| Antibodies to human eotaxin Grant 7,423,129 - Ponath , et al. September 9, 2 | 2008-09-09 |
| Human chemotactic cytokine App 20080070300 - Ponath; Paul D. ; et al. | 2008-03-20 |
| Human chemotactic cytokine Grant 7,285,620 - Ponath , et al. October 23, 2 | 2007-10-23 |
| Human chemotactic cytokine Grant 7,265,201 - Ponath , et al. September 4, 2 | 2007-09-04 |
| Methods of diagnosing and treating inflammatory diseases using pac-1 (dusp2) App 20070054321 - Jeffrey; Kate ; et al. | 2007-03-08 |
| Therapeutic and prophylactic compositions and uses therefor App 20070043512 - Rolph; Michael ; et al. | 2007-02-22 |
| Human chemotactic cytokine App 20060141567 - Ponath; Paul D. ; et al. | 2006-06-29 |
| NEOKINE protein and nucleic acid molecules and uses therefor App 20040019917 - Barnes, Thomas M. ; et al. | 2004-01-29 |
| Neokine protein and nucleic acid molecules and uses therefor App 20020166133 - Barnes, Thomas M. ; et al. | 2002-11-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 